These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29472618)

  • 21. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
    J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.
    Basu A; Chakrabarti G; Saha A; Bandyopadhyay S
    Immunology; 2000 Feb; 99(2):305-13. PubMed ID: 10692051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
    Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
    Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The circulating immunoglobulins negatively impact on the parasite clearance in the liver of Leishmania donovani-infected mice via dampening ROS activity.
    Srinontong P; Wu Z; Sato K; Nagaoka H; Maekawa Y
    Biochem Biophys Res Commun; 2018 Nov; 506(1):20-26. PubMed ID: 30336975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential Role of Leptin as an Immunomodulator in Controlling Visceral Leishmaniasis in Normal and Leptin-Deficient Mice.
    Maurya R; Bhattacharya P; Ismail N; Dagur PK; Joshi AB; Razdan K; McCoy JP; Ascher J; Dey R; Nakhasi HL
    Am J Trop Med Hyg; 2016 Jul; 95(1):109-119. PubMed ID: 27114296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis.
    Das P; Amit A; Singh SK; Chaudhary R; Dikhit MR; Yadav A; Pandey K; Das VN; Sundram S; Das P; Bimal S
    Parasitol Int; 2015 Feb; 64(1):18-25. PubMed ID: 25224164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis.
    Oghumu S; Gupta G; Snider HM; Varikuti S; Terrazas CA; Papenfuss TL; Kaplan MH; Satoskar AR
    Eur J Immunol; 2014 Feb; 44(2):450-9. PubMed ID: 24242758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
    Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS
    J Immunol; 1999 Nov; 163(10):5519-25. PubMed ID: 10553079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of
    Dey S; Mukherjee D; Sultana SS; Mallick S; Dutta A; Ghosh J; Hussain A; Sarkar B; Mandal S; Patra P; Saha B; Pal C
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32229617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Absence of HIF-1α Increases Susceptibility to Leishmania donovani Infection via Activation of BNIP3/mTOR/SREBP-1c Axis.
    Mesquita I; Ferreira C; Moreira D; Kluck GEG; Barbosa AM; Torrado E; Dinis-Oliveira RJ; Gonçalves LG; Beauparlant CJ; Droit A; Berod L; Sparwasser T; Bodhale N; Saha B; Rodrigues F; Cunha C; Carvalho A; Castro AG; Estaquier J; Silvestre R
    Cell Rep; 2020 Mar; 30(12):4052-4064.e7. PubMed ID: 32209468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis.
    Singh N; Sundar S
    PLoS One; 2018; 13(6):e0199817. PubMed ID: 29953494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
    Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
    FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-33/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection.
    Lamberet A; Rostan O; Dion S; Jan A; Guegan H; Manuel C; Samson M; Gangneux JP; Robert-Gangneux F
    Parasit Vectors; 2020 Jun; 13(1):320. PubMed ID: 32571430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with kala-azar.
    Ghosh M; Mandal L; Maitra S; Rakshit S; Paul K; Bagchi J; Ganguly D; Pal C; Bandyopadhyay S
    J Infect Dis; 2006 Aug; 194(3):294-301. PubMed ID: 16826476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo immunomodulatory properties of octyl-β-D-galactofuranoside during Leishmania donovani infection.
    Guegan H; Ory K; Belaz S; Jan A; Dion S; Legentil L; Manuel C; Lemiègre L; Vives T; Ferrières V; Gangneux JP; Robert-Gangneux F
    Parasit Vectors; 2019 Dec; 12(1):600. PubMed ID: 31870416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection.
    Gorak PM; Engwerda CR; Kaye PM
    Eur J Immunol; 1998 Feb; 28(2):687-95. PubMed ID: 9521079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
    Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
    PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.